Clearside Biomedical (CLSD) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

CLSD is expected to report earnings to rise 28.30% to -12 cents per share on November 06

Clearside Biomedical CLSD Stock Earnings Reports

Q3'24

Est.

$-0.13

Q2'24

Beat

by $0.03

Q1'24

Missed

by $0.03

Q4'23

Beat

by $0.01

Q3'23

Beat

by $0.01

The last earnings report on August 12 showed earnings per share of -10 cents, beating the estimate of -12 cents. With 219.93K shares outstanding, the current market capitalization sits at 72.50M.

View a ticker or compare two or three

Compare

CLSD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CLSD
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of drug therapies to treat chronic, blinding diseases of the eye

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

900 North Point Parkway

Phone

+1 678 270-3631

Employees

Web

https://www.clearsidebio.com